54 135 (Mycophenolate mofetil 500 mg)

Pill imprint 54 135 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; pulmonary fibrosis; organ transplant, rejection prophylaxis; bullous pemphigoid (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil

Imprint:

54 135

Strength:

500 mg

Color:

White

Size:

1.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Selective immunosuppressants

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Roxane Laboratories, Inc.

National Drug Code (NDC):

00054-0166

Inactive Ingredients:

croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
corn starch
titanium dioxide
triacetin
polyethylene glycol
povidone

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.